Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Experimental cardiac arrest and resuscitation uses aged animals

Dec. 10, 2015

Technique devised for imaging platelets in thrombosis models

Dec. 10, 2015

Theravance initiates first-in-human study of NEP inhibitor TD-0714

Dec. 9, 2015

Novel neprilysin inhibitors exhibit good renal profile

Dec. 9, 2015

Consortium invests in Athera Biotechnologies to further development of PC-mAB

Dec. 7, 2015

Pfizer outlines the discovery of the myeloperoxidase inhibitor PF-06282999

Dec. 4, 2015

Vericiguat holds promise for heart failure

Dec. 1, 2015

Bayer Schering Pharma divulges sGC activators

Nov. 30, 2015

Fibroblast activation inhibitor preserves cardiac function after heart failure in animal model

Nov. 30, 2015

Bayer Schering Pharma divulges sGC activators

Nov. 27, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...